Investigational Drug Details
| Drug ID: | D023 |
| Drug Name: | AZD4017 |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | DB14875 |
| DrugBank Description: | AZD-4017 is under investigation in clinical trial NCT01173471 (A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure). |
| PubChem ID: | 24946280 |
| CasNo: | 1024033-43-9 |
| Repositioning for NAFLD: | No |
| SMILES: | S(CCC)c1nc(ccc1C(=O)NC1CCCCC1)N1C[C@H](CC(=O)O)CCC1 |
| Structure: |
|
| InChiKey: | NCDZABJPWMBMIQ-INIZCTEOSA-N |
| Molecular Weight: | 419.591 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | 11B-HSD1 inhibitor |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 2 terminated (NCT02605616: Astra Zeneca notified Dr. Rita Basu that they will not manufacture new drug due to business reasons and study was stopped.) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0601 | NCT02605616 | Phase 2 | Not recruiting | No Results Available | 18/09/2015 | 12 December 2020 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|